You just read:

Novo Nordisk Receives FDA Approval of Tresiba® (insulin degludec injection 100 U/mL, 200 U/mL) for Use in Children and Adolescents With Diabetes

News provided by

Novo Nordisk

Dec 19, 2016, 14:00 ET